Selas Bio-Clinic is a Paris medical biology laboratory offering diagnostic testing for hospitals, clinics and patients in France.
Founded in 1995 and headquartered in Paris, France, Selas Bio-Clinic runs a medical biology laboratory that provides diagnostic tests across hematology, biochemistry, immunology and microbiology. The company was acquired in January 2019 by Amundi Private Equity, Andera Partners, IDIA Capital Investissement and SOCADIF Capital Investissement from Azulis Capital and Galia Gestion. In 2023 it reported revenue of EUR 25,873,989.60 and an EBITDA of EUR 1,501,500.20.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in